PMC:7228307 / 41939-42050 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"720","span":{"begin":55,"end":59},"obj":"Gene"}],"attributes":[{"id":"A720","pred":"tao:has_database_id","subj":"720","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T753","span":{"begin":55,"end":57},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T218","span":{"begin":60,"end":68},"obj":"Chemical"}],"attributes":[{"id":"A218","pred":"chebi_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"720","span":{"begin":55,"end":59},"obj":"Gene"}],"attributes":[{"id":"A720","pred":"pubann:denotes","subj":"720","obj":"Gene:2213"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T235","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}

{"project":"LitCovid-sentences","denotations":[{"id":"T235","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, the challenge for the development of more potent FcγR effector mAbs is to overcome three major obstacles."}